Acquisition will strengthen and add scale to current functional services offering to meet growing demand

London, UK: September 26, 2016 –PAREXEL

... Read more

BOSTON, August 1, 2016- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the appointment of four company

... Read more

PAREXEL Wins Best Technological Development In Clinical Trial Award At The 11th Annual Scrip Awards

LONDON, December 18, 2015 - PAREXEL International Corporation (NASDAQ: PRXL), a

... Read more

Comprehensive wearables and sensors solution, powered by the Perceptive MyTrials® Analytics platform, creates greater efficiencies for biopharmaceutical

... Read more

ParkerVision Enters into Patent License and Settlement Agreement with

... Read more

ParkerVision Names

... Read more

ParkerVision Enters into Patent License and Settlement Agreement with

... Read more

Parnell Pharmaceuticals Holdings Ltd

... Read more

Patriot drills highest grade lithium drill intercept to date

... Read more

Patriot drills 52.2 m of 3.34% Li₂O, including 15.0 m of 5.10%

... Read more